Lilly rides Mounjaro, Zepbound to better-than-expected 1Q profit despite supply issues
Tuesday, April 30th 2024, 3:07:16 pm
article
Rapidly climbing sales of the new obesity drug Zepbound and its counterpart for diabetes, Mounjaro, pushed Eli Lilly to a better-than-expected first-quarter profit
Breaking
The group of 10 banks plans to introduce its euro stablecoin next year under a new Dutch entity named Qivalis....
Costco says it faces an urgent deadline under customs law that threatens its ability to recover the duties it has already paid....
